Covalent fragment-based drug discovery as a strategy to combat leishmaniasis

Read full text Summarise with VIRAT
Authors: Maria Cristina Nonato
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Covalent inhibition has emerged as a powerful strategy in drug discovery, offering a unique combination of potency, selectivity, and sustained target engagement.Building on our previous findings-where we identified barbituric acid derivatives as orotate bioisosteres that, upon introduction of an exocyclic double bond, acted as covalent inhibitors of Leishmania braziliensis dihydroorotate dehydrogenase (LbDHODH)-we now report a new series of conjugated dienebarbituric acid compounds derived from the most potent previously identified inhibitor, 2i, a nanomolar compound with antiparasitic activity.

Fields of Study & Subjects

Research on Leishmaniasis Studies Synthesis and Characterization of Heterocyclic Compounds Heterocyclic Compound Synthesis and Bioactivity

Publication details

Journal / source
Acta Crystallographica Section A Foundations and Advances
Volume
81
Issue
a1
Pages
e45–e45
Publication date
30 March 2026
Language
EN